{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:15Z","timestamp":1792791495454,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["T32AR53461-16"],"award-info":[{"award-number":["T32AR53461-16"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS134672"],"award-info":[{"award-number":["U01NS134672"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ymthe.2025.07.013","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T07:38:35Z","timestamp":1752651515000},"page":"4834-4847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["AAV-microutrophin gene therapy confers durable cardioprotection against pharmacologic and exercise-induced injury in the mdx mouse"],"prefix":"10.1016","volume":"33","author":[{"given":"Coral M.","family":"Kasden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Corzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufranshell","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaine","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Arany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Kozyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-1815","authenticated-orcid":false,"given":"Hansell H.","family":"Stedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.07.013_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000512647","article-title":"Duchenne and Becker Muscular Dystrophies' Prevalence in MD STARnet Surveillance Sites: An Examination of Racial and Ethnic Differences","volume":"55","author":"Zhang","year":"2021","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ymthe.2025.07.013_bib2","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.4187\/respcare.07131","article-title":"Impact of Mechanical Ventilation Methods on the Life Perception of Subjects With Duchenne Muscular Dystrophy: French Cross-Sectional Survey","volume":"65","author":"Boussaid","year":"2020","journal-title":"Respir. Care"},{"key":"10.1016\/j.ymthe.2025.07.013_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.013_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a Vector for Gene Therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2025.07.013_bib5","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.molmed.2020.09.010","article-title":"Journey to the Center of the Cell: Tracing the Path of AAV Transduction","volume":"27","author":"Dhungel","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.07.013_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymthe.2006.03.014","article-title":"Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8","volume":"14","author":"Inagaki","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.013_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","article-title":"Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals","volume":"50","author":"Koenig","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.07.013_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nm0302-253","article-title":"Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy","volume":"8","author":"Harper","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.07.013_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/343180a0","article-title":"Very mild muscular dystrophy associated with the deletion of 46% of dystrophin","volume":"343","author":"England","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.013_bib10","author":"Sarepta Therapeutics"},{"key":"10.1016\/j.ymthe.2025.07.013_bib11","author":"Marks"},{"key":"10.1016\/j.ymthe.2025.07.013_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165869","article-title":"Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"9","author":"Hart","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.07.013_bib14","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin Immunity after Gene Therapy for Duchenne's Muscular Dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.07.013_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41598-024-84077-w","article-title":"Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapy","volume":"15","author":"Potter","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.07.013_bib16","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.nmd.2023.07.035","article-title":"T-cell response to SRP-9001 dystrophin transgene in a patient treated with Delandistrogene Moxeparvovec: a case of immune-mediated myositis","volume":"33","author":"Khan","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.07.013_bib19","series-title":"Sarepta Therapeutics Shares Safety Update on ELEVIDYS","year":"2025"},{"key":"10.1016\/j.ymthe.2025.07.013_bib20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41591-019-0594-0","article-title":"Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models","volume":"25","author":"Song","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.07.013_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtm.2018.10.005","article-title":"Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2\/mdx Mice","volume":"11","author":"Kennedy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.013_bib22","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/anie.201912392","article-title":"Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid","volume":"59","author":"Wilkinson","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ymthe.2025.07.013_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1038\/mt.2008.149","article-title":"Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin\/utrophin-deficient mice","volume":"16","author":"Odom","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.013_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/sj.mt.6300144","article-title":"Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure","volume":"15","author":"Townsend","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.013_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000068446","article-title":"The heart in human dystrophinopathies","volume":"99","author":"Finsterer","year":"2003","journal-title":"Cardiology"},{"key":"10.1016\/j.ymthe.2025.07.013_bib26","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1096\/fj.01-0030fje","article-title":"Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury","volume":"15","author":"Danialou","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2025.07.013_bib27","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-Deficient Cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-8703(98)70057-2","article-title":"Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study","volume":"135","author":"Sasaki","year":"1998","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2025.07.013_bib29","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/mt.2008.52","article-title":"Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle","volume":"16","author":"Townsend","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.013_bib30","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/14.5.669","article-title":"Discrepancy between systolic and diastolic dysfunction of the left ventricle in patients with Duchenne muscular dystrophy","volume":"14","author":"Takenaka","year":"1993","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymthe.2025.07.013_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/mus.21716","article-title":"Timeline of cardiac dystrophy in 3-18-month-old MDX mice","volume":"42","author":"Van Erp","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.013_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2019.01.013","article-title":"Acute AT(1)R blockade prevents isoproterenol-induced injury in mdx hearts","volume":"128","author":"Meyers","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib33","article-title":"Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy","volume":"5","author":"Parvatiyar","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.ymthe.2025.07.013_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cvr\/cvu119","article-title":"Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy","volume":"103","author":"Li","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2025.07.013_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15632-x","article-title":"Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4","volume":"7","author":"Perera","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.07.013_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jacbts.2019.01.009","article-title":"Cardiac Muscle Membrane Stabilization in Myocardial Reperfusion Injury","volume":"4","author":"Houang","year":"2019","journal-title":"JACC. Basic Transl. Sci."},{"key":"10.1016\/j.ymthe.2025.07.013_bib37","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","article-title":"Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy","volume":"94","author":"Melacini","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.07.013_bib38","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2014.03.027","article-title":"Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction","volume":"63","author":"Rittoo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.782695","article-title":"Systematic Review and Meta-Analysis of Endurance Exercise Training Protocols for Mice","volume":"12","author":"Massett","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib40","article-title":"Accelerating the Mdx Heart Histo-Pathology through Physical Exercise","volume":"11","author":"Morroni","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ymthe.2025.07.013_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-016-9536-9","article-title":"The fibrosis-cell death axis in heart failure","volume":"21","author":"Piek","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ymthe.2025.07.013_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/352536a0","article-title":"The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy","volume":"352","author":"Stedman","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.013_bib43","series-title":"Cardiomyopathy - Disease of the Heart Muscle","article-title":"Clinical Management of DMD-Associated Cardiomyopathy","author":"Lee-Gannon","year":"2021"},{"key":"10.1016\/j.ymthe.2025.07.013_bib44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1136\/heartjnl-2017-311269","article-title":"A current approach to heart failure in Duchenne muscular dystrophy","volume":"103","author":"D'Amario","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ymthe.2025.07.013_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.107.162982","article-title":"Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin\/utrophin expression","volume":"102","author":"Bostick","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.07.013_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/genes8040108","article-title":"Dystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel Therapies","volume":"8","author":"Johnstone","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymthe.2025.07.013_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2613.2010.00750.x","article-title":"Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy","volume":"92","author":"Au","year":"2011","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.nmd.2004.04.007","article-title":"Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings","volume":"14","author":"Quinlan","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.07.013_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells12111538","article-title":"RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy","volume":"12","author":"Marcadet","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.07.013_bib50","doi-asserted-by":"crossref","first-page":"19079","DOI":"10.1073\/pnas.1013077107","article-title":"Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy","volume":"107","author":"Adamo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.07.013_bib51","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejpn.2013.12.009","article-title":"Assessment of cardiac autonomic function in patients with Duchenne muscular dystrophy using short term heart rate variability measures","volume":"18","author":"Dhargave","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib52","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13023-022-02473-9","article-title":"Electrocardiographic features of children with Duchenne muscular dystrophy","volume":"17","author":"Tang","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.07.013_bib53","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mus.10223","article-title":"Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy","volume":"26","author":"Chu","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.013_bib54","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-8703(94)90672-6","article-title":"Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study","volume":"127","author":"de Kermadec","year":"1994","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ymthe.2025.07.013_bib55","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/01.CIR.94.9.2285","article-title":"Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure","volume":"94","author":"Eichhorn","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.07.013_bib56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.07.013_bib57","doi-asserted-by":"crossref","first-page":"H1253","DOI":"10.1152\/ajpheart.00578.2001","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib58","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.1996.03530410049032","article-title":"Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies","volume":"275","author":"Politano","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2025.07.013_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-G","article-title":"The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy","volume":"26","author":"Nigro","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib60","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/21678707.2016.1234373","article-title":"Managing dystrophinopathic cardiomyopathy","volume":"4","author":"Politano","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ymthe.2025.07.013_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248933","article-title":"Adaptive versus maladaptive cardiac remodelling in response to sustained beta-adrenergic stimulation in a new 'ISO on\/off model","volume":"16","author":"Werhahn","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.07.013_bib62","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.109.199489","article-title":"Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage","volume":"105","author":"Michele","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2025.07.013_bib63","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1152\/japplphysiol.00231.2002","article-title":"Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy","volume":"93","author":"Kemi","year":"2002","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib64","first-page":"97","article-title":"The athlete's heart vs. the failing heart: can signaling explain the two distinct outcomes?","volume":"26","author":"Weeks","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.ymthe.2025.07.013_bib65","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI0214190","article-title":"TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II","volume":"109","author":"Schultz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.07.013_bib66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardiores.2004.04.030","article-title":"TGF-beta1 and angiotensin networking in cardiac remodeling","volume":"63","author":"Rosenkranz","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2025.07.013_bib67","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/labinvest.2016.52","article-title":"Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-beta","volume":"96","author":"Khan","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymthe.2025.07.013_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cardiores.2004.04.031","article-title":"Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence","volume":"63","author":"Selvetella","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ymthe.2025.07.013_bib69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.yjmcc.2010.03.018","article-title":"New insights into the molecular phenotype of eccentric hypertrophy","volume":"49","author":"Sciarretta","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib70","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1152\/ajpregu.00340.2011","article-title":"Ventricular function during exercise in mice and rats","volume":"302","author":"Lujan","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.013_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5607507","article-title":"Blood Pressure Response to Submaximal Exercise Test in Adults","volume":"2016","author":"Wielemborek-Musial","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.07.013_bib72","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12968-023-00922-3","article-title":"Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance","volume":"25","author":"Earl","year":"2023","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ymthe.2025.07.013_bib73","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.echo.2008.03.001","article-title":"Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy","volume":"21","author":"Mertens","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ymthe.2025.07.013_bib74","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41586-024-08310-2","article-title":"Structure and assembly of the dystrophin glycoprotein complex","volume":"637","author":"Wan","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.013_bib75","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41586-024-08324-w","article-title":"Native DGC structure rationalizes muscular dystrophy-causing mutations","volume":"637","author":"Liu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.013_bib76","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.nmd.2011.07.008","article-title":"A single 30 min treadmill exercise session is suitable for 'proof-of concept studies' in adult mdx mice: a comparison of the early consequences of two different treadmill protocols","volume":"22","author":"Radley-Crabb","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.07.013_bib77","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JND-150106","article-title":"Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients","volume":"2","author":"Hyzewicz","year":"2015","journal-title":"J. Neuromuscul. Dis."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625005489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:08Z","timestamp":1792788488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625005489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1525001625005489"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.013","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV-microutrophin gene therapy confers durable cardioprotection against pharmacologic and exercise-induced injury in the mdx mouse","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}